| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/07/2007 | CA2062829C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 08/02/2007 | WO2007087631A2 Cobalamin compositions for the treatment of cancer |
| 08/02/2007 | WO2007087624A2 Transluminal drug delivery methods and devices |
| 08/02/2007 | WO2007087609A2 Formulations and methods for treating dry eye |
| 08/02/2007 | WO2007087585A1 Piperazinyl derivatives as modulators of chemokine receptor activity |
| 08/02/2007 | WO2007087577A2 Drug delivery system for retarding release of water soluble drugs |
| 08/02/2007 | WO2007087575A2 Compositions and methods for treating pulmonary hypertension |
| 08/02/2007 | WO2007087572A2 Aza-peptide epoxides |
| 08/02/2007 | WO2007087557A2 Surface-layer protein coated microspheres and uses thereof |
| 08/02/2007 | WO2007087549A2 Chemical compounds |
| 08/02/2007 | WO2007087548A2 Chemical compounds |
| 08/02/2007 | WO2007087534A2 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 08/02/2007 | WO2007087524A2 Treatment of acute respiratory distress syndrome |
| 08/02/2007 | WO2007087506A2 Compounds for the treatment of metabolic disorders |
| 08/02/2007 | WO2007087505A2 Compounds for the treatment of metabolic disorders |
| 08/02/2007 | WO2007087504A2 Compounds for the treatment of metabolic disorders |
| 08/02/2007 | WO2007087448A1 Spiro imidazole derivatives as ppar modulators |
| 08/02/2007 | WO2007087443A2 Vinyl-phenyl derivatives for inflammation and immune-related uses |
| 08/02/2007 | WO2007087442A2 Substituted biaryl compounds for inflammation and immune-related uses |
| 08/02/2007 | WO2007087441A2 Substituted aromatic compounds for inflammation and immune-related uses |
| 08/02/2007 | WO2007087431A2 Sublingual fentanyl spray |
| 08/02/2007 | WO2007087429A2 Phenyl and pyridyl compounds for inflammation and immune-related uses |
| 08/02/2007 | WO2007087427A2 Thiazole and thiadiazole compounds for inflammation and immune-related uses |
| 08/02/2007 | WO2007087425A1 Methods and compositions for treating schizophrenia |
| 08/02/2007 | WO2007087424A2 Method of treating kcnq related disorders using organozinc compounds |
| 08/02/2007 | WO2007087419A2 Substituted 3-(5-membered unsaturated heterocyclyl) -1, 3-dihydro-indol-2-one derivatives as tyrosine kinase inhibitors for the treatment of cancer |
| 08/02/2007 | WO2007087416A2 Methods of increasing oral bioavailability of tetracyclines |
| 08/02/2007 | WO2007087395A2 UNSATURATED mTOR INHIBITORS |
| 08/02/2007 | WO2007087367A2 Methods and compositions for modulating the mobilization of stem cells |
| 08/02/2007 | WO2007087344A2 Anti-histamine compositions and use thereof |
| 08/02/2007 | WO2007087283A2 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 08/02/2007 | WO2007087276A1 Aurora kinase modulators and method of use |
| 08/02/2007 | WO2007087250A2 Tricyclic inhibitors of 5-lipoxygenase |
| 08/02/2007 | WO2007087246A2 Jak2 tyrosine kinase inhibition |
| 08/02/2007 | WO2007087245A2 Ret tyrosine kinase inhibition |
| 08/02/2007 | WO2007087231A2 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/02/2007 | WO2007087224A2 Hexahydro-3h-pyrrolizin-3-ones useful as tachykinin receptor antagonists |
| 08/02/2007 | WO2007087220A2 The total synthesis of ecteinascidin 743 and derivatives thereof |
| 08/02/2007 | WO2007087215A2 N-acetyl-cysteine and its derivatives as an antitussive |
| 08/02/2007 | WO2007087151A2 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 08/02/2007 | WO2007087150A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 08/02/2007 | WO2007087148A1 Crystalline forms of 3-biphenyl-4-yl-(2s)-[(4'-trifluoromethyl-biphenyl-4-carbonyl)-amino]-propionic acid, and methods of use |
| 08/02/2007 | WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS |
| 08/02/2007 | WO2007087129A2 Fluorinated arylamide derivatives |
| 08/02/2007 | WO2007087068A2 Inhibitors of tyrosine kinases and uses thereof |
| 08/02/2007 | WO2007087056A2 Peramivir derivative for oral administration |
| 08/02/2007 | WO2007087029A2 Use of low-dose ladostigil for neuroprotection |
| 08/02/2007 | WO2007087026A2 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 08/02/2007 | WO2007086948A1 Dnt-fumarate and methods of preparation thereof |
| 08/02/2007 | WO2007086943A2 Wortmannin conjugates and uses thereof |
| 08/02/2007 | WO2007086929A1 Nanoparticle formation of pharmaceutical ingredients |
| 08/02/2007 | WO2007086923A2 Controlled and sustained gene transfer mediated by thiol-modified polymers |
| 08/02/2007 | WO2007086914A2 Nanoparticulate clopidogrel formulations |
| 08/02/2007 | WO2007086895A2 Antibacterial compounds and uses thereof |
| 08/02/2007 | WO2007086891A1 Levetiracetam formulations and methods for their manufacture |
| 08/02/2007 | WO2007086884A2 Organic nitric oxide donor salts of antimicrobial compounds, compositions and methods of use |
| 08/02/2007 | WO2007086800A1 Novel heteroaryl substituted benzothiazoles |
| 08/02/2007 | WO2007086799A1 Amide substituted quinolines |
| 08/02/2007 | WO2007086689A1 A solid dispersion comprising ubidecarenone, a process for preparing the same and a pharmaceutical composition comprising the same |
| 08/02/2007 | WO2007086663A1 Hif-1 alpha activating agent |
| 08/02/2007 | WO2007086651A1 Anti-cancer agent loaded hydrophobic bile acid conjugated hydrophilic chitosan oligosaccharide nanoparticles and preparation method thereof |
| 08/02/2007 | WO2007086605A1 Method for prediction of the effect of sulfonamide compound |
| 08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
| 08/02/2007 | WO2007086582A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME |
| 08/02/2007 | WO2007086565A1 Growth hormone secretion regulator |
| 08/02/2007 | WO2007086554A1 Tropane compound and pharmaceutical composition containing the same as active ingredient |
| 08/02/2007 | WO2007086541A2 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 08/02/2007 | WO2007086536A2 Soft-gelatin capsule formulation |
| 08/02/2007 | WO2007086526A1 Gene polymorphism and use thereof |
| 08/02/2007 | WO2007086504A1 Carboxylic acid compound and use thereof |
| 08/02/2007 | WO2007086493A1 Medicine for transnasal administration |
| 08/02/2007 | WO2007086480A1 Composition for normalizing blood pressure |
| 08/02/2007 | WO2007086471A1 Process for production of lasofoxifene or analogue thereof |
| 08/02/2007 | WO2007086457A1 Quickly disintegrating tablet produced by direct dry-tabletting |
| 08/02/2007 | WO2007086446A1 Pharmaceutical composition for prevention or treatment of cardiac failure |
| 08/02/2007 | WO2007086395A1 Photodynamic therapy kit |
| 08/02/2007 | WO2007086361A1 Ameliorating agent for aluminum storage disease |
| 08/02/2007 | WO2007086354A1 Novel histidine derivative |
| 08/02/2007 | WO2007086327A1 Dermal papilla cell growth promoter |
| 08/02/2007 | WO2007086100A1 Composition having effect of lowering blood pressure and/or inhibiting increase in blood pressure and food and drink containing the same |
| 08/02/2007 | WO2007086080A2 NOVEL IMIDAZO[1,2-a]PYRIDINE CANNABINOID RECEPTOR LIGANDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 08/02/2007 | WO2007086044A1 Adenosine a3 receptor agonists for the treatment of dry eye disorders |
| 08/02/2007 | WO2007086016A1 Tetrahydropyrane antibiotics |
| 08/02/2007 | WO2007086014A1 Formulation comprising cefpirome, tazobactam and linezolid |
| 08/02/2007 | WO2007086013A1 Formulation comprising of ceftazidime, tazobactam and linezolid |
| 08/02/2007 | WO2007086012A1 Formulation of cefpodoxime, clavulanic acid and linezolid |
| 08/02/2007 | WO2007086011A1 Formulation comprising cefepime, tazobactam and linezolid |
| 08/02/2007 | WO2007085933A2 Process for the preparation of n-[1-(s)-ethoxycarbonyl-1-butyl]-(s)-alanine-dmt complex and its use in the preparation of perindopril |
| 08/02/2007 | WO2007085873A1 Treatment of alzheimer's disease and related conditions |
| 08/02/2007 | WO2007085806A2 Therapeutic delivery of carbon monoxide |
| 08/02/2007 | WO2007085750A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 08/02/2007 | WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof |
| 08/02/2007 | WO2007085679A1 Preparation of beta-carboline from natural products and foods having monoaminooxidase (mao) inhibiting activity |
| 08/02/2007 | WO2007085676A1 Method for producing a solution based on polyethylene glycol with electrolytes, product thus obtained and use of same |
| 08/02/2007 | WO2007085652A1 Use of the (s) enantiomer of mequitazine for preparing a medicament, while at the same time limiting genomic toxicity |
| 08/02/2007 | WO2007085637A1 Tamper resistant dosage forms |
| 08/02/2007 | WO2007085629A2 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents |
| 08/02/2007 | WO2007085615A1 Process for loading polymer particles with drug |
| 08/02/2007 | WO2007085567A2 Synergistic compositions for treating hiv |
| 08/02/2007 | WO2007085558A1 Use of 2-imidazoles for the treatment of cns disorders |